« Back to news listing

Insulet Announces $85 Million Deal with Cannacord Genuity

Insulet, a diabetes management company based in Bedford, Massachusetts, announced that it entered a new deal with Canaccord Genuity. The new deal will give Canaccord Genuity an $85 million stake in Insulet’s common stock.

Read entire article: http://www.qmed.com/news/insulet-announces-85-million-deal-cannacord-genuity?cid=nl_qmed_daily

« Back to news listing